These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8612478)

  • 21. Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations.
    Rossel M; Pasini A; Chappuis S; Geneste O; Fournier L; Schuffenecker I; Takahashi M; van Grunsven LA; Urdiales JL; Rudkin BB; Lenoir GM; Billaud M
    Oncogene; 1997 Jan; 14(3):265-75. PubMed ID: 9018112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia types 1 and 2.
    Ellard S
    Methods Mol Med; 2004; 92():267-83. PubMed ID: 14733317
    [No Abstract]   [Full Text] [Related]  

  • 23. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of MEN2A- or 2B-type RET mutations in primary neuroblastoma tumour tissue.
    Peaston AE; Camacho ML; Norris MD; Haber M; Marsh DJ; Robinson BG; Hyland VJ; Marshall GM
    Mol Cell Probes; 1998 Aug; 12(4):239-42. PubMed ID: 9727201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 2: molecular aspects.
    Mulligan LM
    Front Horm Res; 2001; 28():81-102. PubMed ID: 11443855
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RET in human development and oncogenesis.
    Edery P; Eng C; Munnich A; Lyonnet S
    Bioessays; 1997 May; 19(5):389-95. PubMed ID: 9174404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
    DeLellis RA
    Lab Invest; 1995 May; 72(5):494-505. PubMed ID: 7745945
    [No Abstract]   [Full Text] [Related]  

  • 29. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.
    Iwashita T; Asai N; Murakami H; Matsuyama M; Takahashi M
    Oncogene; 1996 Feb; 12(3):481-7. PubMed ID: 8637703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
    Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different mutations of the RET gene cause different human tumoral diseases.
    Santoro M; Melillo RM; Carlomagno F; Visconti R; De Vita G; Salvatore G; Fusco A; Vecchio G
    Biochimie; 1999 Apr; 81(4):397-402. PubMed ID: 10401675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
    Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
    Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
    Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline mutation of the RET proto-oncogene in members of Slovak families with multiple endocrine neoplasia 2.
    Poturnajova M; Altanerov V; Kettmann R; Feikova S; Hlubinova K; Balazovjech I; Breza J; Fodo G; Knotek J; Matoska J; Podobov M; Altaner C
    Neoplasma; 2001; 48(6):445-50. PubMed ID: 11949835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel sequence variants of the genes associated with the multiple endocrine neoplasia syndromes 1 and 2. analysis by an "in silico approach.".
    Igaz P; Patócs A; Rácz K
    J Endocrinol Invest; 2002; 25(7):609-13. PubMed ID: 12150335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.
    Blaugrund JE; Johns MM; Eby YJ; Ball DW; Baylin SB; Hruban RH; Sidransky D
    Hum Mol Genet; 1994 Oct; 3(10):1895-7. PubMed ID: 7849720
    [No Abstract]   [Full Text] [Related]  

  • 40. The RET proto-oncogene in sporadic pheochromocytomas.
    Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
    Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.